IDAYATU OMONIYI: Open Payments
NPI 1174282826 · TINLEY PARK, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$777 in 16 payments from 7 companies in 2025. Trend: 2023 $151 · 2024 $166 · 2025 $777
Food & beverage: $777
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 5 | $179 |
| E.R. Squibb & Sons, L.L.C. | 2 | $160 |
| Otsuka America Pharmaceutical, Inc. | 4 | $157 |
| Teva Pharmaceuticals USA, Inc. | 1 | $119 |
| Janssen Pharmaceuticals, Inc | 2 | $110 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $26 |
| ABBVIE INC. | 1 | $26 |
Products named: INGREZZA, COBENFY, REXULTI, UZEDY, INVEGA SUSTENNA, REJOYN, VRAYLAR.
Industry payments across IL — which companies pay providers there.
